301 results found. Viewing page 47 of 61.
Go to page . . . . . .
In the September 2013 issue of The Journal of Immunotherapy, researchers from the Western University of Australia published results of a study using a promising new immunotherapy compound and its effects on reoccurring mesothelioma tumors in lab ...
Continue Reading...
The Wall Street Journal is continuing its practice of spreading asbestos trust fraud propaganda in its recent piece, “ Exposing Asbestos Fraud.” The piece alleges that the judiciary is standing in the way of justice and that a judge ...
Continue Reading...
Researchers at Chiba University in Japan recently examined the response of mesothelioma cells when treated with a combination of two statin drugs commonly used to lower cholesterol and paired with a form of vitamin E called gamma tocotrienol (y-T3). ...
Continue Reading...
The Chemical Safety Improvement Act of 2013 (S. 1009) (CSIA) is a bill currently before congress. The legislation is designed to reform the Toxic Substances Control Act (TSCA) of 1976. Many public health advocates who support TSCA reform do not ...
Continue Reading...
The Australian Asbestos Diseases Research Institute (ADRI) has announced a clinical trial for a newly developed drug therapy in the treatment of mesothelioma. Researchers at the ADRI conducted a three year study focused on the genetic characteristics ...
Continue Reading...
301 results found. Viewing page 47 of 61.
Go to page . . . . . .